Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.

Raquibul Hannan,Michael Christensen,Liliana Robles,Alana Christie,Aurelie Garant,Neil Desai,Hans J. Hammers,Waddah Arafat,Isaac Alexander Bowman,Suzanne Cole,Kevin D. Courtney,Solomon L. Woldu,Aditya Bagrodia,Vitaly Margulis,Jeffrey A. Cadeddu,Hak Choy,David J. Sher,James Brugarolas

Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.

2021

Raquibul Hannan
Michael Christensen
Liliana Robles
Alana Christie
Aurelie Garant
Neil Desai
Hans J. Hammers
Waddah Arafat
Isaac Alexander Bowman
Suzanne Cole
Kevin D. Courtney
Solomon L. Woldu
Aditya Bagrodia
Vitaly Margulis
Jeffrey A. Cadeddu
Hak Choy
David J. Sher
James Brugarolas

311Background: Stereotactic ablative radiotherapy (SAbR) is a promising treatment option for selected oligometastatic renal cell carcinoma (RCC) patients that can provide longitudinal disease contr...

Keywords:

Kidney cancer
SABR volatility model
treatment options
Radiation therapy
Renal cell carcinoma
Radiology
Ablative case
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations